Medicare Enrolled

Dr. Jerry Martel, M.D., M.P.H.

Gastroenterology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
8950 N KENDALL DR STE 306W, Miami, FL 33176
3055969966
In practice since 2007 (18 years)
NPI: 1477755668 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Martel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Martel

Dr. Jerry Martel is a gastroenterology in Miami, FL, with 18 years in practice. Based on federal Medicare data, Dr. Martel performed 274 Medicare services across 244 unique beneficiaries.

Between the years covered by Open Payments, Dr. Martel received a total of $421,147 from 48 pharmaceutical and/or device companies across 1513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Martel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ 274 Medicare services$ $421,147 industry payments

Medicare Practice Summary

Medicare Utilization ↗
274
Medicare services
Bottom 17% in FL for gastroenterology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
244
Unique beneficiaries
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~15 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)90$99$348
Hospital follow-up visit, moderate complexity41$69$237
Removal of polyps or growths of large bowel using an endoscope with mechanical snare33$236$1,426
Upper GI endoscopy with biopsy29$93$1,198
Initial hospital admission, moderate complexity27$114$455
New patient office visit (45-59 min)26$127$542
Colonoscopy with biopsy17$83$1,500
New patient office visit (30-44 min)11$78$358
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$421,147
Total received (2018-2024)
Avg $60,164/year across 7 years
Top 1% in FL for gastroenterology
48
Companies
1,513
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$406,755 (96.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,556 (2.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,837 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$160,828
2023
$69,696
2022
$53,081
2021
$35,058
2020
$7,215
2019
$47,295
2018
$47,974

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$180,783
GENZYME CORPORATION
$95,144
Regeneron Healthcare Solutions, Inc.
$48,816
QOL Medical, LLC
$34,025
Phathom Pharmaceuticals, Inc.
$26,207
Synergy Pharmaceuticals Inc
$22,379
Janssen Biotech, Inc.
$2,071
Ardelyx, Inc.
$1,694
ABBVIE INC.
$1,255
PFIZER INC.
$1,113
Takeda Pharmaceuticals U.S.A., Inc.
$961
AbbVie Inc.
$947
AbbVie, Inc.
$810
Celgene Corporation
$566
Intercept Pharmaceuticals, Inc.
$513
Ironwood Pharmaceuticals, Inc
$484
RedHill Biopharma Inc.
$432
Ferring Pharmaceuticals Inc.
$378
Gilead Sciences, Inc.
$281
IRONWOOD PHARMACEUTICALS, INC
$196
Romark Laboratories, LC
$195
Daiichi Sankyo Inc.
$193
AIMMUNE THERAPEUTICS, INC.
$191
Braintree Laboratories, Inc.
$171
Madrigal Pharmaceuticals
$170
Janssen Scientific Affairs, LLC
$150
Allergan Inc.
$145
INTERCEPT PHARMACEUTICALS, INC.
$135
Celltrion USA Inc.
$97
Lilly USA, LLC
$77
FUJIFILM Medical Systems USA, Inc.
$73
EVOKE PHARMA, INC.
$56
Merck Sharp & Dohme LLC
$55
Covidien LP
$40
Amgen Inc.
$39
Nestle HealthCare Nutrition Inc.
$39
VIVUS LLC
$38
Ipsen Biopharmaceuticals, Inc
$34
Merck Sharp & Dohme Corporation
$31
Ethicon US, LLC
$24
Ambu Inc.
$23
Concordia Pharmaceuticals Inc.
$22
Endo Pharmaceuticals Inc.
$20
Organon LLC
$19
NESTLE HEALTHCARE NUTRITION INC.
$17
Medtronic, Inc.
$17
PENTAX of America, Inc.
$11
GI Supply, Inc.
$10
Top 3 companies account for 77.1% of total payments
Associated products mentioned in payments ›
ALINIA · AMITIZA · AMJEVITA · APRISO · AVSOLA · Aemcolo · Alinia Tablets 500mg 30 count bottle · Amitiza · CIMZIA · CLENPIQ · CREON · Creon · DIFICID · DOPTELET · DUPIXENT · Dexilant · Donnatal · ELIQUIS · ENTYVIO · EOHILIA · ESD - Core Endoscopy · Edarbi · Entyvio · GI GENIUS · GIMOTI · HUMIRA · Humira · IBSRELA · IMAGINA · INFLECTRA · INJECTAFER · IQIRVO · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · MOVIPREP · Mavyret · Movantik · NASCOBAL · OCALIVA · OMVOH · PANCREAZE · PLENVU · PREPOPIK · PillCam · Qsymia · REBYOTA · RELISTOR · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TALICIA · TREMFYA · TRULANCE · Talicia · Trintellix · TruClear · Trulance · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for gastroenterology in FL.

Equivalent to $153,703 per 100 Medicare services performed
Looking for a gastroenterology in Miami?
Compare gastroenterologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
156
Per 100K population
5.8
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Martel is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 1%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Martel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Martel performed 90 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Martel receive payments from pharmaceutical companies?
Yes. Dr. Martel received a total of $421,147 from 48 companies across 1,513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martel's costs compare to other gastroenterologys in Miami?
Dr. Martel's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →